Skip to main content

Market Overview

Cytokinetics, Incorporated (NASDAQ: CYTK)

24.70 -0.17 (-0.68%)

Analyst Ratings

DateResearch FirmActionCurrentPT
3/12/21Wolfe ResearchInitiates Coverage OnOutperform50.0
1/20/21HC Wainwright & Co.MaintainsBuy41.0
12/16/20Morgan StanleyMaintainsOverweight24.0
11/16/20Morgan StanleyMaintainsOverweight22.0
10/29/20Goldman SachsInitiates Coverage OnNeutral16.0
10/12/20Morgan StanleyMaintainsOverweight24.0
10/08/20HC Wainwright & Co.MaintainsBuy43.0
7/23/20Piper SandlerMaintainsOverweight36.0
7/23/20HC Wainwright & Co.MaintainsBuy59.0
7/16/20NeedhamMaintainsBuy45.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter